Affiliate disclosure and scope
We earn a commission if you buy through the links on this page. All details were checked on 8 August 2026.
This article is informational only and is not medical advice. If you are using kratom to manage opioid withdrawal or pain, SAMHSA’s National Helpline is 1-800-662-4357 — free, confidential, 24/7.
Read This Before Anything Else
Kratom’s principal alkaloids — mitragynine and 7-hydroxymitragynine, which is far more potent — act as partial agonists at mu-opioid receptors, the same receptor family targeted by morphine and oxycodone.
It produces tolerance, physical dependence and a withdrawal syndrome.
We open every kratom review this way because the category’s marketing is built on strain names and colours that invite you to shop as though choosing tea. You are choosing an opioid-receptor agonist, and that fact is prior to any question about which vendor sells it best.
We Checked the Lab Reports Page
Third-party coverage of this vendor describes it as testing all products and “diligently uploading each lab report for your review.” That would be genuinely good — it is the standard we praised at one CBD brand with a searchable batch database and criticised a kratom retailer for failing, since that one would only supply certificates if you emailed to ask.
So we opened the lab reports page.
Two reports were displayed — Instant Kava Kava Powder and Traditional Kava Kava Powder. Both as downloadable PDFs.
No kratom lab reports were linked at all, despite kratom being the primary product category and the reason almost anyone visits.
Also absent from the page:
- Any mitragynine or 7-hydroxymitragynine figure
- The identity of the testing laboratory
- Organisation by batch or lot number
- Any detail of which analyses were performed — heavy metals, microbials, pesticides
This is why we check rather than relay. We were prepared to credit this vendor for published testing on the strength of secondary reporting, and the credit did not survive opening the page. A lab reports page with no reports for your main product is infrastructure without content.
The Notice Explaining Why
To their considerable credit, the company does not leave that unexplained. The page carries a notice:
“Lab reports are currently being updated. New federal restrictions on 7-hydroxymitragynine took effect this month, and we are refreshing our full testing panel to demonstrate compliance.”
Correction, added after publication: the premise of that notice is not accurate. No federal restriction on 7-hydroxymitragynine took effect in that month. The DEA published a notice of intent to schedule concentrated 7-OH temporarily in July 2026, and as of August 2026 the order had not issued — 7-hydroxymitragynine does not appear in the Schedule I listings at 21 CFR 1308.11. We originally repeated the company’s framing without checking it, and we should have checked it.
We want to give that its due, because it is unusual. The easy option would have been to leave stale certificates up and say nothing — which is what a seller trying to obscure something would do. Instead they removed them, said so, and named the reason.
It also independently corroborates the regulatory picture we have set out across this series. We have written in earlier reviews that the DEA began temporary scheduling to place concentrated 7-OH into Schedule I from 1 July 2026, following an FDA recommendation in July 2025. Here is a seller, in the middle of it, reorganising its testing panel because of exactly that.
Why the Timing Matters More Than the Gap
Here is the part that decides how much the candour is worth, and it is uncomfortable.
The kratom testing data is unavailable during precisely the period when 7-OH content is the live question. The compound driving a federal scheduling action is the one you currently cannot see a figure for — and the reports are down because of that action.
The explanation is honest and the position is still bad for the buyer. Both are true simultaneously. A shop can be candid about why it cannot show you something and you can still be unable to see it.
The practical consequence is simple: this is a poor moment to buy kratom here. Not because the company is behaving badly — the notice suggests the opposite — but because the single thing you would most want to check is temporarily absent, by the company’s own account. Wait until the refreshed panel is published, then look at it.
And when it appears, check what it actually contains. A panel refreshed specifically to demonstrate 7-OH compliance ought to state a 7-OH figure. If the new reports arrive without one, that tells you something.
Extracts Again, With No Figure Again
The company is called Top Extracts, and extracts are in the product line — alongside powder, capsules, crushed leaf and liquid kratom.
We found no mitragynine percentage, no 7-hydroxymitragynine figure, and no concentration ratio on the kratom pages we read. Not for the powders, and not for the extracts.
This is now the third kratom seller in this series where the compound governing both potency and legality is the number that does not appear. The pattern is not incidental to the category — it appears to be the category.
Why unlabelled extracts matter more than unlabelled leaf: 7-OH occurs in dried leaf at roughly 0.011 to 0.039% by weight, and the American Kratom Association’s position is that genuine kratom holds 7-OH below 2% of total alkaloids. Extraction and enrichment can move that figure by orders of magnitude — one state attorney general has sued over products found at 96% 7-OH, nearly fifty times that state’s limit.
We make no allegation about this seller’s products. That is precisely the point: nobody can tell, including the buyer, because the figure is not published — and right now the lab reports that might have contained it are down.
What an AKA Badge Is and Is Not
The site displays American Kratom Association and AHPA compliance badges. Those deserve precise treatment, because this series has repeatedly found trade-association membership sitting in the visual register of certification.
| A displayed association badge | AKA GMP Qualified Vendor | |
|---|---|---|
| Basis | Affiliation or stated compliance | Comprehensive third-party inspection of facilities, documentation and labelling |
| Rechecked? | No inspection implied | Annual independent audit required |
| What it entitles a seller to say | Varies | Only that it passed an independent third-party audit |
We could not confirm that Top Extracts holds GMP Qualified Vendor status, and it did not appear among qualified vendors in what we could read. Absence of confirmation is not proof of absence — the list changes and our search was not exhaustive — but the two things should not be read as equivalent by a buyer looking at a badge.
One important deflation in the other direction, in fairness to every vendor. The AKA is explicit that GMP qualification is not an endorsement of product quality — a Qualified Vendor may represent only that it passed an independent third-party audit against the programme standards. It is a process credential, not a quality guarantee, and even the vendor we rated highest in this category holds nothing stronger than that.
What They Do Better Than Others Here
This review has been critical, so here is what genuinely distinguishes this seller from the worst of the category — and it is more than nothing.
- A named founder and a real history. Founded in 2014 by Jim Sourek, grown from a physical Chicago botanical shop. In a category full of anonymous storefronts, knowing who is responsible is not a small thing.
- Twelve years of trading without an enforcement action we could locate.
- Lab report infrastructure exists, with downloadable PDFs — currently sparse on kratom, but the mechanism is built rather than promised.
- The candid notice. Removing reports and explaining why is the opposite of leaving stale files up, and we would rather see it than not.
- A broad legitimate botanical range — kava, CBD oil, turmeric, echinacea — suggesting a botanical retailer rather than a kratom-only operation.
None of that substitutes for an alkaloid figure. But it is the difference between a business with accountability and a website, and we should say so.
The Kava Sitting Next to It
The kava range includes Yellow Piper Methysticum, Traditional Solomon Kava Kava and a 60% supercritical CO2 kava extract. Ironically, kava is the one product line with published lab reports.
Kava carries a hepatotoxicity signal. It has been associated with liver injury and has faced regulatory restriction in several countries on that basis. Kratom also carries a liver-injury signal, with cholestatic hepatitis reported in the literature.
Selling them separately is considerably better than combining them, which is what we found at another retailer offering a single kava-and-kratom shot. But someone buying both from the same shop can combine them at home, and the sensible default with two independent liver signals is not to stack them and find out. We could find no interaction study of the combination.
Where It Is Illegal
Leaf kratom is not federally scheduled in the US. State law is a different matter.
As of July 2026, nine states ban kratom outright: Alabama, Arkansas, Connecticut, Indiana, Louisiana, Tennessee, Vermont and Wisconsin.
Counties and municipalities ban it independently, so a state-level green light is not the end of the question. Rhode Island reversed its 2017 ban on 1 April 2026 — reportedly the first state to do so.
And the federal position on concentrated 7-OH is separate from the state position on leaf — which is exactly what this seller’s own notice is responding to. Check your jurisdiction at the point of ordering, because the law is moving in both directions.
Side Effects and Who Must Not Use It
- Pregnant. Neonatal withdrawal following maternal kratom use is documented.
- Breastfeeding.
- Taking any opioid, benzodiazepine, sedative or alcohol. Combined respiratory depression is the mechanism behind a substantial share of serious kratom-associated cases.
- Taking an SSRI, SNRI, MAOI, tramadol or another serotonergic drug.
- Living with liver disease, or taking anything else with a hepatotoxicity signal — which on this site includes the kava sold alongside it.
- Under 21.
Reported effects include nausea, vomiting, constipation, itching, dizziness, sedation, tachycardia, seizure, liver injury, dependence and withdrawal. The constipation point matters on this site specifically: opioid-receptor activity slows gut transit, GLP-1 medications already commonly cause constipation, and there is no interaction safety data for kratom alongside GLP-1 drugs. Kratom is not a weight-loss product and has not been studied as one.
How It Compares to Other Kratom Sellers
| Top Extracts | Super Speciosa | Kratom Country | |
|---|---|---|---|
| AKA GMP qualified | Not confirmed; badge displayed | Yes, among the first | Not established |
| Kratom COAs visible today | None — page shows kava only | Testing programme documented | Email to request |
| Alkaloid figure published | None found | Leaf-focused range | None found |
| Named founder and history | Yes — 2014, Chicago shop | Florida operation named | Not established |
| Our rating | 1.7 / 5 | 2.0 / 5 | 1.6 / 5 |
No kratom seller scores well here, because the ceiling is set by what the substance is rather than by how well anyone sells it. Within that ceiling, AKA GMP qualification is what separates the top of this table, and a currently-empty kratom testing page is what keeps this one near the bottom of it.
Pros and Cons
Pros
- Named founder and a twelve-year trading history from a physical shop
- Lab report infrastructure exists, with downloadable PDFs
- Candidly explained why kratom reports are currently absent
- Published kava certificates of analysis
- Broad legitimate botanical range rather than a kratom-only operation
- No FDA warning letter or enforcement action naming this seller located
Cons
- Kratom acts on mu-opioid receptors; dependence and withdrawal are expected
- No kratom lab reports published at the time we checked
- Testing data absent during the exact period 7-OH compliance is the live question
- No mitragynine or 7-OH figure found anywhere, including on extracts
- No concentration ratio given for extracts
- No testing laboratory named; reports not organised by batch
- AKA and AHPA badges displayed, but GMP Qualified Vendor status not confirmed
- Kava sold alongside kratom — two independent liver signals in one basket
- Banned outright in nine states, plus local ordinances
Our Recommendation, and Harm Reduction
Our recommendation is not to buy kratom, and that is about the substance rather than this seller. If you are going to anyway, the specific advice here is unusual:
Wait for the refreshed lab panel before buying kratom from this vendor. The company says it is rebuilding its testing to demonstrate 7-OH compliance. Let it finish, then read what it publishes — and check specifically whether a 7-OH figure appears, because a panel refreshed for that purpose ought to contain one.
- Prefer leaf powder over extracts, which carry the entire unlabelled-potency problem.
- Do not combine kratom and kava, for the liver reason above.
- Never combine with opioids, benzodiazepines, sedatives or alcohol. This is the combination behind the serious cases.
- Check your state and your city, and note the federal 7-OH position is separate and moving.
- Keep any dose low and stable, and avoid daily use. Tolerance is the mechanism that turns occasional use into dependence.
- Tell your doctor you are taking it, particularly before surgery.
If you are using it for opioid withdrawal or unmanaged pain, a clinician is the better route. SAMHSA National Helpline: 1-800-662-4357.
Limitations of This Review
We have not bought, used or independently tested any Top Extracts product.
Our central finding is a snapshot, and the company says so itself. We read the lab reports page on 8 August 2026 and found two kava reports and no kratom ones, during a period the site describes as an active rebuild of its testing panel. That position may already have changed, and it would be unfair to treat a stated transition as a permanent characteristic. Check the page yourself.
The absence of alkaloid figures is an absence we searched for and did not find on the pages we read; figures may appear on individual product pages, packaging, or documents we did not reach. We could not confirm AKA GMP Qualified Vendor status either way — our search of the qualified vendor list was not exhaustive, the list changes, and a vendor could have qualified since. We found no FDA action naming this seller, but absence of a search finding is not proof of absence. We did not read a Trustpilot or BBB record and publish no satisfaction score, and we could not establish pricing.
The regulatory position is moving fast. The seller’s own notice refers to new federal 7-OH restrictions taking effect “this month”, which is consistent with the scheduling process we have documented but which we have not independently verified as to its current form or scope. Verify current federal and state law yourself. None of this is medical or legal advice.
Frequently Asked Questions
What is kratom, in plain terms?
A tree leaf whose main alkaloids, mitragynine and the far more potent 7-hydroxymitragynine, act as partial agonists at mu-opioid receptors — the same receptor family as morphine and oxycodone. It produces tolerance, dependence and a withdrawal syndrome. That is the first fact about this product, not a footnote to it.
Does Top Extracts publish lab reports?
It has a lab reports page, which is more than several sellers we have reviewed. But when we checked it, only two reports were actually displayed — Instant Kava Kava Powder and Traditional Kava Kava Powder — and no kratom lab reports were linked at all, despite kratom being the primary product line.
Why are the kratom reports missing?
The site says so directly: "Lab reports are currently being updated. New federal restrictions on 7-hydroxymitragynine took effect this month, and we are refreshing our full testing panel to demonstrate compliance." That is a candid explanation and we credit the candour — but the practical position for anyone buying today is that there is no published kratom testing to inspect.
Is the alkaloid content disclosed?
We found no mitragynine or 7-hydroxymitragynine percentage or milligram figure anywhere on the kratom pages we read, and none on the extracts either — no concentration ratio, no alkaloid figure. That is the third kratom seller in this series where the compound governing both potency and legality is the number not printed.
Is it an AKA GMP Qualified Vendor?
We could not confirm that it is. American Kratom Association and AHPA compliance badges are displayed on the site, but those are not the same thing as GMP Qualified Vendor status, which rests on a comprehensive third-party inspection of facilities, documentation and labelling, and requires passing an independent audit annually. Absence of confirmation is not proof of absence, but the two designations should not be read as equivalent.
What does AKA GMP qualification actually certify?
Less than people assume, and the association is explicit about it. A Qualified Vendor may only represent that it passed an independent third-party audit showing compliance with the programme standards. The AKA does not endorse product quality — only that an auditor verified the standards are being met. It is a process credential, not a quality guarantee.
What is good about this seller?
Real accountability, which is rarer in this category than it should be. It was founded in 2014 by a named individual, Jim Sourek, grew from a physical Chicago botanical shop, has lab report infrastructure even if currently sparse on kratom, and posted a candid notice explaining the gap rather than quietly leaving stale files up.
Where is kratom banned?
As of August 2026, eight states ban it outright: Alabama, Arkansas, Connecticut, Indiana, Louisiana, Tennessee, Vermont and Wisconsin. Counties and municipalities ban it independently of state law, and Rhode Island reversed its 2017 ban on 1 April 2026. Check your own jurisdiction, because this is moving in both directions.
Verdict
1.7 / 5
A more accountable business than most in this category, whose kratom testing page currently contains no kratom testing — honestly explained, and still the wrong moment to buy.
Every kratom review here starts from the same fact: mitragynine and 7-OH are partial agonists at mu-opioid receptors, and dependence is an expected outcome rather than a rare complication. That caps what any seller in this category can score.
We were prepared to credit this one for published testing. Third-party coverage describes it as diligently uploading every lab report — the standard we have praised elsewhere and criticised a rival for failing. Then we opened the page. Two reports, both for kava. No kratom reports at all, no laboratory named, no batch organisation, and no alkaloid figures — for a business whose primary category is kratom.
To their credit, they say why: reports are being updated because “new federal restrictions on 7-hydroxymitragynine took effect this month” and the testing panel is being refreshed to demonstrate compliance. Removing stale certificates and explaining the gap is the opposite of what a seller hiding something would do. Note, though, that the stated reason is wrong on the facts: no federal restriction on 7-OH took effect that month, and the compound is still absent from 21 CFR 1308.11.
But the timing is the problem, not the candour. The kratom data is unavailable during precisely the period when 7-OH content is the live legal and safety question — the compound driving a federal action is the one you currently cannot see a figure for. An honest explanation and an unusable position are not mutually exclusive.
The extracts compound it. No concentration ratio, no alkaloid figure — the third kratom seller in this series where the number governing potency and legality simply does not appear. Given 7-OH sits at 0.011 to 0.039% in leaf and one state attorney general has sued over products at 96%, unlabelled means unbounded. And the displayed AKA and AHPA badges are not GMP Qualified Vendor status, which we could not confirm — though in fairness, even that qualification is a process credential the association expressly says is not an endorsement of product quality.
They are more accountable than most of this category. A named founder, a twelve-year history from a real Chicago shop, built testing infrastructure, published kava certificates and a candid notice. That is the difference between a business and a storefront — and none of it substitutes for the figure that is missing.
If you are buying kratom anyway, wait for the refreshed panel and then read it — and check whether it actually states a 7-OH figure. A testing programme rebuilt specifically to demonstrate 7-OH compliance ought to contain one.
Wait for the Lab Panel, Then Read It
When we checked, the lab reports page carried two kava certificates and no kratom ones, with a notice saying the panel is being refreshed because new federal 7-hydroxymitragynine restrictions took effect. That is honest, and it also means the thing you would most want to check is currently unavailable - so this is a poor moment to buy kratom here. Wait, then read what appears, and check specifically for a 7-OH figure. Prefer leaf over extracts, which carry the whole unlabelled-potency problem. Do not combine kratom with kava, and never with opioids, benzodiazepines, sedatives or alcohol. Kratom acts on the same receptor family as opioids and causes dependence; if you are managing withdrawal or pain, call SAMHSA on 1-800-662-4357. This page is informational only and is not medical or legal advice.